Cary Street Partners Investment Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $239K | Buy |
3,462
+264
| +8% | +$18.2K | 0.12% | 196 |
|
2025
Q1 | $217K | Buy |
3,198
+510
| +19% | +$34.6K | 0.12% | 201 |
|
2024
Q4 | $121K | Sell |
2,688
-9,910
| -79% | -$445K | 0.08% | 244 |
|
2024
Q3 | $792K | Sell |
12,598
-4,256
| -25% | -$268K | 0.03% | 396 |
|
2024
Q2 | $995K | Sell |
16,854
-160,775
| -91% | -$9.5M | 0.04% | 347 |
|
2024
Q1 | $14.2M | Buy |
177,629
+3,283
| +2% | +$262K | 0.6% | 39 |
|
2023
Q4 | $13.8M | Sell |
174,346
-7,128
| -4% | -$563K | 0.66% | 32 |
|
2023
Q3 | $12.7M | Buy |
181,474
+74,233
| +69% | +$5.18M | 0.68% | 32 |
|
2023
Q2 | $7.41M | Buy |
107,241
+854
| +0.8% | +$59K | 0.48% | 53 |
|
2023
Q1 | $7.91M | Sell |
106,387
-1,332
| -1% | -$99K | 0.57% | 47 |
|
2022
Q4 | $10M | Sell |
107,719
-3,033
| -3% | -$283K | 0.74% | 42 |
|
2022
Q3 | $10.6M | Buy |
110,752
+9,496
| +9% | +$906K | 0.87% | 30 |
|
2022
Q2 | $9.38M | Buy |
101,256
+94,094
| +1,314% | +$8.72M | 0.8% | 32 |
|
2022
Q1 | $724K | Buy |
7,162
+2,399
| +50% | +$243K | 0.2% | 126 |
|
2021
Q4 | $491K | Buy |
4,763
+441
| +10% | +$45.5K | 0.14% | 155 |
|
2021
Q3 | $367K | Buy |
4,322
+324
| +8% | +$27.5K | 0.12% | 164 |
|
2021
Q2 | $334K | Buy |
3,998
+30
| +0.8% | +$2.51K | 0.11% | 178 |
|
2021
Q1 | $299K | Sell |
3,968
-8,155
| -67% | -$615K | 0.12% | 165 |
|
2020
Q4 | $828K | Sell |
12,123
-79,925
| -87% | -$5.46M | 0.16% | 134 |
|
2020
Q3 | $5.38M | Buy |
+92,048
| New | +$5.38M | 1.14% | 15 |
|